Holen Sie sich die Stockscreener-App
108.87
2.48%
2.63
Handel nachbörslich:
109.67
0.80
+0.73%
Insmed Inc Aktie (INSM) Neueste Nachrichten
Insmed CEO defends BRINSUPRI launch as sales surge, TPIP pipeline gains focus - MSN
Insmed (INSM) Slides 3% as Investors Weigh Recent Shelf Registration and Post-earnings Reset - Moomoo
Insider Sell Alert: Michael Smith Sells 6,149 Shares of Insmed I - GuruFocus
Insmed chief legal officer Michael Smith sells $666,982 in shares By Investing.com - Investing.com Australia
Insmed chief legal officer Michael Smith sells $666,982 in shares - Investing.com
Insmed (INSM) slides 3% as investors weigh recent shelf registration and post-earnings reset - Quiver Quantitative
INSM: Michael Smith (INSM) files Form 144 reporting share dispositions - Stock Titan
Insmed Insider Sold Shares Worth $666,982, According to a Recent SEC Filing - Moomoo
Insmed (INSM) legal chief sells 6,149 shares under Rule 10b5-1 plan - Stock Titan
Insmed (INSM) CEO sells shares, exercises options under 10b5-1 plan - Stock Titan
TD Cowen Initiates Insmed(INSM.US) With Buy Rating, Announces Target Price $243 - Moomoo
Competitive Pressures Prompt Truist to Cut Target on Insmed (INSM) - Insider Monkey
INSM, FSLR, APTV: Dreaded death cross has formed on these stocks — what it means for investors - MSN
11 Best Long Term US Stocks to Buy Right Now - Insider Monkey
Assessing Insmed (INSM) Valuation After Recent Share Price Pullback And Strong Multi Year Returns - Yahoo Finance
Insmed's Q1 earnings beat, sales miss estimates, stock tanks 23% - MSN
William Blair Maintains Insmed(INSM.US) With Buy Rating - Moomoo
Analyst Reaffirms Buy on Insmed, Citing Strong ENCORE Phase IIIb Arikayce Data and TPIP IPF Upside - TipRanks
William Lewis lists proposed INSM share sales (05/2026) — INSM - Stock Titan
Insmed To Present at March 2026 Investor Conferences - GuruFocus
UBS Maintains Insmed(INSM.US) With Buy Rating, Cuts Target Price to $166 - Moomoo
Insmed, Inc. $INSM Shares Purchased by iA Global Asset Management Inc. - MarketBeat
Insmed Incorporated (INSM): Investor Outlook Reveals 84% Upside Potential Amidst Biotech Innovations - DirectorsTalk Interviews
Insmed CEO Defends BRINSUPRI Launch as Sales Surge, TPIP Pipeline Gains Focus - sharewise.com
AustralianSuper Pty Ltd Takes $1.74 Million Position in Insmed, Inc. $INSM - MarketBeat
Insmed CFO Sara Bonstein sells $961k in company stock - Investing.com UK
Insmed Inc files for mixed shelf offering size not disclosedSEC filing - marketscreener.com
Insmed Inc Files For Mixed Shelf Offering Size Not DisclosedSEC Filing - TradingView
Insmed (NASDAQ: INSM) files shelf registration to enable future stock and debt offers - Stock Titan
Darwin Global, affiliates hold 7.8% of INSMED (INSM) in 13G/A filing - Stock Titan
Insmed CFO Sara Bonstein sells $961k in company stock By Investing.com - Investing.com South Africa
Insmed Insiders Sold Shares Worth Over $3.2M - TradingView
Insmed (NASDAQ: INSM) director awarded 3,305 RSUs, now holds 246,081 shares - Stock Titan
Insmed (INSM) CFO sells 8,272 shares to cover RSU tax obligations - Stock Titan
Insmed (INSM) director Carol Schafer awarded 3,305 RSUs in equity grant - Stock Titan
INSMED (INSM) COO Roger Adsett sells 5,837 shares to cover RSU taxes - Stock Titan
Insmed (INSM) director granted 3,305 RSUs vesting after one year - Stock Titan
Insmed (NASDAQ: INSM) CMO sells 18,333 shares under Rule 10b5-1 plan - Stock Titan
Insmed (INSM) legal chief sells 4,109 shares to cover RSU taxes - Stock Titan
INSMED Inc (INSM) director Brennan receives 3,305 RSUs and reports 124,238 total shares - Stock Titan
Insmed (NASDAQ: INSM) director receives 3,305 RSUs equity award - Stock Titan
Director Leo Lee (NASDAQ: INSM) receives 3,305 RSUs equity grant - Stock Titan
INSMED (INSM) CEO Lewis sells 13,283 shares to cover RSU tax obligations - Stock Titan
Insmed (NASDAQ: INSM) investors approve board picks, pay and auditor - Stock Titan
NYLI Fiera SMID Growth Fund's Insmed Inc(INSM) Holding History - GuruFocus
INSM Maintained by Truist Securities -- Price Target Lowered to $185 - GuruFocus
[144] INSMED Inc SEC Filing - Stock Titan
Insmed stock (US4576693075): Truist cuts price target to $185 on competitive risks - AD HOC NEWS
Truist Financial Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $185 - Moomoo
Insmed | 4: Statement of changes in beneficial ownership of securities-Officer Flammer Martina M.D. - Moomoo
0.12%
1.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):